EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The TET3/GATA6 Axis Drives Lipid Metabolism and Therapeutic Vulnerabilities in Pancreatic Ductal Adenocarcinoma (Adv. Sci. 37/2025)

Shuai Liu, Shaobo Kang, Na Lin, Wenqi Zhang, Shiwen Wang, Yuqing Ren, Xiaofan Ding, Jianxiu Yu, Ruiyu Xie

Advanced Science · 2025-10 · 12 (37)

DOI: 10.1002/advs.71801 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 06.10.2025. Verfasst von Shuai Liu und 8 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic Ductal Adenocarcinoma In article number 2501774, Ruiyu Xie and co-workers demonstrate that TET3 plays a non-canonical role in regulating lipid metabolism in pancreatic ductal adenocarcinoma (PDAC) by recruiting histone deacetylases (HDACs) to repress GATA6. This repression sustains the expression of lipogenic enzymes (SCD, FASN, ACSL3) and promotes resistance to ferroptosis. Targeting the TET3/GATA6 axis represents a promising therapeutic strategy to overcome metabolic vulnerabilities in advanced pancreatic cancer.

Zitieren

APA

Liu, S., Kang, S., Lin, N., Zhang, W., Wang, S., Ren, Y., Ding, X., Yu, J., & Xie, R. (2025). The TET3/GATA6 Axis Drives Lipid Metabolism and Therapeutic Vulnerabilities in Pancreatic Ductal Adenocarcinoma (Adv. Sci. 37/2025). Advanced Science, 12(37). https://doi.org/10.1002/advs.71801

Vancouver

Liu S, Kang S, Lin N, Zhang W, Wang S, Ren Y, et al. The TET3/GATA6 Axis Drives Lipid Metabolism and Therapeutic Vulnerabilities in Pancreatic Ductal Adenocarcinoma (Adv. Sci. 37/2025). Advanced Science. 2025;12(37). doi:10.1002/advs.71801

BibTeX
@article{Liu2025,
  author = {Liu, Shuai and Kang, Shaobo and Lin, Na and Zhang, Wenqi and Wang, Shiwen and Ren, Yuqing and Ding, Xiaofan and Yu, Jianxiu and Xie, Ruiyu},
  title = {The TET3/GATA6 Axis Drives Lipid Metabolism and Therapeutic Vulnerabilities in Pancreatic Ductal Adenocarcinoma (Adv. Sci. 37/2025)},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {37},
  doi = {10.1002/advs.71801}
}
Kostenlos starten →